Erin McEvoy

This Q&A with Maypro's Lauren Clardy discusses the innovation areas—from scientific substantiation to delivery systems—set to define the future of skin and hair health.

The ingredient manufacturer's ingredients now appear in a vaginal microbiome capsule and an allergy oral strip, signaling broader category use for pro- and postbiotics.

At this year’s The Outlook on Active Nutrition, Joey Savage, founder of Savage Nutra, gives supplement makers an "honest scorecard" of where the research stands and where human data is still needed.

Trade groups say the law's broad criteria could restrict access to supplements with uses beyond weight loss or muscle building.

At The Outlook on Active Nutrition, Doug Kalman, PhD, RD, FISSN, outlines where GLP-1 drugs are falling short, and where nutraceutical brands can step in.

The retail commercialization firm outlines its post-event strategy for emerging and international wellness brands entering the U.S. market, following the ECRM Vitamin, Weight Management & Sports Nutrition Session.

Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.

The company's newest chewable concepts pair postbiotics with biotin and vitamin D3 to support skin, hair, and immune health.

The company's "IVC Advantage" pairs market research with formulation and manufacturing scale for brands launching products.

Ahead of the Las Vegas trade show, BSCG outlines how its five certification programs address banned substances, label accuracy, GMP compliance, and CBD verification.

Research conducted on beauty and nutritional needs for women in Asia-Pacific outlines needs across four life stages and what they mean for supplement formulators.

The ingredient supplier will spotlight Cognizin Citicoline’s push into functional foods and beverages, as well as Setria's 20th anniversary.

The precision-granule platform Tailored Script enters the U.S. and Australian markets, giving brands and practitioners a way to manufacture individualized formulations at scale.

The company introduces Gut & Protein Optimizer, a probiotic-enzyme formula for protein utilization, and NMN 300 mg, an NAD+ precursor.

Built on Calanus Oil and ORIVO-verified fish oil, the concept targets brands seeking faster, differentiated omega-3 product development.

Nova Mentis's HT1 ingredient bypasses olive extraction, aiming to give formulators a more consistent supply of the polyphenol.

The appointment comes as the CDMO continues to expand its gummy, softgel, and fizzy tablet format offerings for brand partners.

Pooled RCT evidence from three EU consortia shows non-nutritive sweeteners may support weight loss maintenance without adverse effects on biomarkers or taste preference.

A year-to-date look at the various forces pushing digestive health formulation toward more precise, mechanism-driven claims.

The >Your< Hydramin+ Sticks target the growing overlap between functional hydration, sports nutrition, and beauty-from-within supplements.

The Dietary Supplement Innovation Act, introduced by Rep. Harshbarger, would cap indefinite preclusion, require science-based review standards, and open FDA warnings to court challenge.

Luigi Cappello joins CEO Tim Condron on Vitaquest's executive team; the company also recently expanded its probiotics manufacturing capacity.

The randomized, double-blind placebo-controlled study found laboratory safety markers remained within normal ranges across treatment and placebo groups.

This overview outlines the clinical background, consumer landscape, and technical developments shaping the gluten-free category.

New research finds 40% of consumers still struggle with digestive upset and points formulators toward function-first messaging over ingredient-first claims.

The partnership pairs Oobli's non-GMO sweet proteins, which offer sugar-like taste but digest as protein, with education initiatives and a consumer-facing platform.

The food-biotech company points to rising Asia-Pacific concern over ultra-processed foods and tightening regulations in China and Indonesia as it presents its Get It Natural Toolbox.

The new yeast-based nutrients, Amberferm Grow 288 and 289, are designed to raise packed cell volume yield and acidification activity in dairy culture production, without added capital investment.

The deal will establish a global Citrus and Beverage Center of Excellence in Florida and follows Mane's recent moves in savory flavors and stevia-based sweeteners.